HomeCompareSIOX vs ADC

SIOX vs ADC: Dividend Comparison 2026

SIOX yields 91.00% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SIOX wins by $2.50M in total portfolio value
10 years
SIOX
SIOX
● Live price
91.00%
Share price
$0.48
Annual div
$0.44
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.68M
Annual income
$847,016.42
Full SIOX calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — SIOX vs ADC

📍 SIOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIOXADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIOX + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIOX pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIOX
Annual income on $10K today (after 15% tax)
$7,735.36/yr
After 10yr DRIP, annual income (after tax)
$719,963.96/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, SIOX beats the other by $651,286.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIOX + ADC for your $10,000?

SIOX: 50%ADC: 50%
100% ADC50/50100% SIOX
Portfolio after 10yr
$1.43M
Annual income
$463,906.86/yr
Blended yield
32.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

SIOX
Analyst Ratings
1
Buy
2
Hold
1
Sell
Consensus: Hold
Altman Z
-17.3
Piotroski
2/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIOX buys
0
ADC buys
0
No recent congressional trades found for SIOX or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIOXADC
Forward yield91.00%4.13%
Annual dividend / share$0.44$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$2.68M$178.9K
Annual income after 10y$847,016.42$80,797.29
Total dividends collected$2.37M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: SIOX vs ADC ($10,000, DRIP)

YearSIOX PortfolioSIOX Income/yrADC PortfolioADC Income/yrGap
1← crossover$19,800$9,100.42$10,990$580.36+$8.8KSIOX
2$38,027$16,840.38$12,301$860.26+$25.7KSIOX
3$70,915$30,226.23$14,104$1,298.62+$56.8KSIOX
4$128,559$52,680.24$16,691$2,008.16+$111.9KSIOX
5$226,813$89,254.37$20,580$3,205.09+$206.2KSIOX
6$389,856$147,166.82$26,754$5,330.02+$363.1KSIOX
7$653,555$236,408.67$37,196$9,345.14+$616.4KSIOX
8$1,069,692$370,388.16$56,244$17,523.09+$1.01MSIOX
9$1,711,136$566,565.23$94,286$35,736.21+$1.62MSIOX
10$2,677,932$847,016.42$178,949$80,797.29+$2.50MSIOX

SIOX vs ADC: Complete Analysis 2026

SIOXStock

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.

Full SIOX Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this SIOX vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIOX vs SCHDSIOX vs JEPISIOX vs OSIOX vs KOSIOX vs MAINSIOX vs NNNSIOX vs EPRTSIOX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.